Proteins and Peptides

31 Mar 2008 Naglazyme Approved by Japanese Ministry of Health
27 Mar 2008 GTC Biotherapeutics and PharmAthene Extend Agreement for Protexia Program
27 Mar 2008 Positive phase III data unveiled for new GnRH blocker degarelix
27 Mar 2008 OMRIX Biopharmaceuticals Initiates Phase II Clinical Trial for Fibrin Patch Product Candidate
26 Mar 2008 Æterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
26 Mar 2008 SemBioSys initiates toxicology study for safflower-produced insulin
26 Mar 2008 Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
20 Mar 2008 Pharming To Receive Negative Opinion On European Marketing Authorization Application For Rhucin(R)
20 Mar 2008 Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
19 Mar 2008 Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
18 Mar 2008 Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
18 Mar 2008 Biolex Announces Presentation of Preclinical Results for Clot Buster BLX-155 at SIR Annual Scientific Meeting
17 Mar 2008 Ipsen and Medicis Announce Submission of Reloxin BLA in Aesthetics to the FDA
17 Mar 2008 Phylogica and Dynamic Microbials sign anti-bacterial deal
17 Mar 2008 Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
14 Mar 2008 Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
14 Mar 2008 MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
14 Mar 2008 Teva Provides Update On Glatiramer Acetate 40mg For Amyotrophic Lateral Sclerosis (Als)
12 Mar 2008 Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin
11 Mar 2008 Oramed Pharmaceuticals Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule
11 Mar 2008 OctoPlus announces publication of Phase I Locteron results in the Journal of Interferon and Cytokine Research
10 Mar 2008 Palatin Technologies, Inc. Reports positive results of a Phase I clinical study with PL-3994 for the treatment of congestive heart failure
10 Mar 2008 Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
07 Mar 2008 Alkermes Provides Update on Inhaled Insulin Program
07 Mar 2008 AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top